<?xml version="1.0" encoding="UTF-8"?>
<svg height="774.0" width="586.5489470707071" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 453.7699890136719 557.1209716796875 L 559.9559936523438 557.1209716796875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 547.6539916992188 L 273.99700927734375 547.6539916992188 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 299.4519958496094 547.6539916992188 L 334.375 547.6539916992188 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 380.01300048828125 525.14599609375 L 523.3889770507812 525.14599609375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 515.6220092773438 L 256.4219970703125 515.6220092773438 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 445.2659912109375 493.114990234375 L 573.3350219726562 493.114990234375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 483.6470031738281 L 252.0570068359375 483.6470031738281 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 277.5119934082031 483.6470031738281 L 312.4909973144531 483.6470031738281 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 458.3059997558594 384.1510009765625 L 493.2279968261719 384.1510009765625 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 352.1199951171875 L 256.4219970703125 352.1199951171875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 523.6160278320312 329.66900634765625 L 573.5059814453125 329.66900634765625 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 320.1449890136719 L 330.2359924316406 320.1449890136719 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 355.6910095214844 320.1449890136719 L 390.614013671875 320.1449890136719 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 467.9429931640625 297.63800048828125 L 559.3319702148438 297.63800048828125 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 288.1700134277344 L 247.6909942626953 288.1700134277344 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 273.2030029296875 288.1700134277344 L 308.1260070800781 288.1700134277344 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 282.84100341796875 246.61399841308594 L 317.7640075683594 246.61399841308594 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 453.6000061035156 214.63900756835938 L 562.5070190429688 214.63900756835938 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 205.11500549316406 L 261.6940002441406 205.11500549316406 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 287.1499938964844 205.11500549316406 L 322.0719909667969 205.11500549316406 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 308.40899658203125 173.13999938964844 L 460.9700012207031 173.13999938964844 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 486.42498779296875 173.13999938964844 L 521.3480224609375 173.13999938964844 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 533.8770141601562 141.1649932861328 L 570.2169799804688 141.1649932861328 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 131.64100646972656 L 319.4649963378906 131.64100646972656 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 344.9200134277344 131.64100646972656 L 379.8429870605469 131.64100646972656 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="91.28200000000004" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">31. </text>
  <text x="221.499,227.203,231.579,235.539,239.915,244.29,248.666,253.042,257.458,259.086,263.958,269.246,271.49399999999997,273.203,278.075,282.451,284.659,289.035,291.659,296.075,297.694,302.566,307.854,310.102,311.81,317.098,321.474,323.682,325.386,329.762,334.138,336.38599999999997,338.059,342.019,346.395,348.603,350.307,354.267,356.475,360.851,364.704,366.912,368.616,372.992,377.408,379.105,383.481,387.897,389.593,391.801,396.177,400.552,404.928,407.552,411.512,415.888,417.592,421.968,425.819,427.523,431.523,433.246,435.454,438.078,442.454,446.83,449.037,455.661,460.037,464.413,466.661,468.282,472.242,476.618,479.242,483.202,484.906,488.866,493.282,494.927,499.303,503.679,508.09499999999997,509.781,514.157,518.533,522.909,527.285,529.909,534.284,538.66,542.62,547.0360000000001,548.672,550.88,555.296,556.949,559.157,561.781,566.157,570.533,572.741" y="91.28200000000004" svg_rhmargin="575.405" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Nezenega ZS, Tafere TE. Patient satisfaction on tuberculosis treatment service and adherence to treat-</text>
  <text x="221.499,228.123,232.499,236.875,239.123,240.775,242.478,246.894,248.598,252.974,257.349,261.725,263.429,265.133,269.133,270.821,275.197,279.573,283.949,285.653,287.861,292.277,293.952,296.16,300.536,304.496,306.2,307.904,309.608,311.816,313.52,317.896,321.896,323.545,327.921,330.169,331.88,337.168,338.872,343.248,347.624,354.247,358.663,360.283,364.243,368.619,372.994,377.37,379.618,381.315,386.603,390.979,395.355,397.563,401.979,403.652,408.94,411.148,415.524,417.228,421.604,425.876,427.58,431.956,434.204,435.91,441.198,447.822,453.56600000000003,455.243,459.619,463.995,468.371,470.075,472.283,476.699,478.373,482.333,486.709,489.333,493.293,494.997,498.957,503.333,507.333,508.987,511.611,515.987,519.947,524.323,528.699,531.323,535.283,539.544,541.792,543.513,547.889,552.265,556.641,561.017,563.2650000000001,564.943,569.319" y="100.80600000000004" svg_rhmargin="573.735" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ment in public health facilities of Sidama zone, South Ethiopia. BMC health services research. 2013; 13</text>
  <text x="221.499,224.123,228.499,231.123,233.331,237.707,242.082,246.458" y="110.274" svg_rhmargin="248.706" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">(1):110.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="123.25599999999997" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">32. </text>
  <text x="221.499,225.875,227.579,229.827,231.534,237.742,242.118,244.36599999999999,246.046,250.422,255.71,260.998,266.286,270.702,272.353,278.56,283.472,285.164,290.452,295.74,300.612,302.82,308.108,313.812,318.724,320.371,325.659,331.363,337.067,342.355,348.059,353.347,359.051,364.648,369.976,371.678,376.55,382.798,384.49,389.778,395.482,400.354,402.562,405.186,410.058,415.762,421.05,426.338,431.942,437.646,443.35,447.726,453.933,459.221,461.429,466.75699999999995,468.396,473.268,478.972,484.259,489.547,494.419,501.043,506.331,511.935,516.847,518.569,520.777,526.5210000000001,528.206,534.83,540.118,545.406,550.694,555.07,559.446" y="123.25599999999997" svg_rhmargin="564.774" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">al. Ge. LEVEL OF PATIENT ADHERENCE TO ANTI-TUBERCULOSIS TREATMENT IN MEKELLE</text>
  <text x="221.499,226.371,232.075,237.363,242.65,248.354,254.058,259.653,264.029,270.237,275.524,277.732,283.06,284.768,290.471,292.679,298.383,303.671,309.375,314.287,315.949,322.157,327.445,332.733,338.02,343.615,348.903,354.191,359.93499999999995,361.643,366.515,372.219,377.507,383.211,388.499,393.787,399.11499999999995,400.761,406.465,411.753,417.457,422.329,427.617,433.321,438.518,440.76599999999996,442.487,447.359,449.567,455.775,461.479,466.767,472.055,474.303,475.936,481.64,487.847,493.551,498.423,504.16700000000003,505.813,511.101,515.973,521.677,523.885,530.093,535.38,537.588,542.876" y="132.78099999999995" svg_rhmargin="545.124" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">TUBERCULOSIS DIRECT OBSERVED THERAPY CENTERS, TIGRAY, NORTH ETHIOPIA.</text>
  <text x="221.499,229.035,235.243,240.947,245.322,251.066,252.737,256.697,262.905,268.609,274.313,280.016,285.304,289.71999999999997,291.344,297.552,302.464,304.157,309.445,315.149,320.437,326.141,332.673,337.961,343.665,348.993,350.701,355.989,361.693,367.437,369.126,374.414,380.118,385.406,391.11,397.643,402.931,408.635,413.923,419.627,424.499,426.707,432.41,437.611,442.027,443.734,449.022,454.726,456.934,462.222,467.926,473.63,478.827,484.115,486.363,488.067,492.443,496.819,501.195,505.571,507.819,509.497,513.873,516.497,520.873,525.249,527.873,530.081,534.457,538.833,543.209,547.482,551.858,556.234" y="142.30499999999995" svg_rhmargin="558.482" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2015; 4(04):166–81.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="155.288" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">33. </text>
  <text x="221.499,225.875,227.619,229.323,235.027,239.402,241.64999999999998,243.326,248.614,252.99,255.198,256.901,261.277,265.653,267.861,271.821,273.56500000000005,275.244,279.62,283.996,288.371,292.747,295.371,299.747,304.123,307.955,312.371,314.078,316.286,320.702,322.412,326.788,331.164,333.372,335.076,337.7,339.908,344.284,348.66,353.035,355.659,359.619,363.995,365.611,369.987,373.947,375.651,379.651,381.315,387.939,392.315,396.691,398.395,402.355,404.059,408.435,412.811,416.811,418.449,422.825,427.201,431.617,433.302,437.678,441.638,445.598,449.974,453.934,455.638,460.014,462.102,466.478,470.894,472.591,474.799,479.175,483.135,485.343,489.719,492.343,496.343,497.989,500.197,504.573,507.23699999999997,508.93,513.306,517.682,522.058,524.682,529.058,533.434,537.81,542.186,544.81,549.069,553.445,557.405,561.821,563.526,567.902" y="155.288" svg_rhmargin="570.15" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">al De. Patients’ adherence to anti-tuberculosis medicines and associated factors for non-adherence at</text>
  <text x="221.499,225.915,227.622,229.83,234.206,236.83,239.038,240.742,245.118,247.742,251.742,253.417,255.625,260.001,264.377,268.337,272.712,274.416,278.792,283.20799999999997,284.824,289.2,293.576,297.536,301.912,303.616,305.824,310.2,311.904,314.152,315.779,321.067,325.443,329.819,332.027,336.443,338.116,345.652,350.028,353.987,356.235,357.901,363.189,365.397,369.773,371.477,375.853,380.229,381.933,386.309,388.557,390.216,396.424,400.8,404.76,406.464,410.84,415.216,417.423,421.799,426.215,427.86,434.484,438.86,443.236,444.94,448.9,453.276,455.02000000000004,456.66,460.62,464.996,469.372,471.996,476.372,480.747,482.49100000000004,484.156,488.532,492.908,497.284,501.66,503.908,505.529,509.905,514.281,516.905,521.281,523.905,526.112,530.488,534.864,539.24,543.513,547.889" y="164.755" svg_rhmargin="550.137" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">a tertiary teaching hospital, South West Ethiopia. Gaziantep Medical Journal 2016; 22(2):55–62.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="177.79399999999998" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">34. </text>
  <text x="221.499,225.875,227.619,229.323,234.611,239.898,244.274,246.522,248.201,253.073,255.697,260.073,264.449,266.657,273.28,277.656,281.933,284.181,285.902,291.19,295.566,299.942,304.318,306.942,311.318,315.694,319.654,324.07,325.7,330.076,336.7,341.076,345.452,349.868,351.495,356.367,360.743,365.119,369.495,372.119,376.079,380.455,382.159,386.535,390.386,392.09,396.09,397.813,402.189,406.565,410.981,412.667,418.371,422.747,429.371,433.746,438.162,439.822,442.03,448.654,455.278,459.654,463.917,468.33299999999997,470.04,475.744,480.12,482.327,484.031,487.991,489.695,494.071,498.447,502.407,506.407,508.08,513.368,515.072,517.696,522.072,526.072,527.753,533.456,537.832,539.536,543.912,546.12,550.496,554.342,556.55,560.926" y="177.79399999999998" svg_rhmargin="565.342" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">al AYe. Treatment Adherence among Tuberculosis and Human Immuno Deficiency Virus Coinfected</text>
  <text x="221.499,226.787,231.163,233.371,235.075,239.45,243.826,246.034,250.034,251.659,253.363,257.779,259.483,265.691,267.395,271.771,276.147,277.851,280.515,282.216,287.92,292.296,294.504,298.88,301.504,304.128,308.504,310.24800000000005,311.924,317.628,322.004,325.964,330.34,332.044,334.147,338.523,340.227,342.47499999999997,344.182,349.47,356.094,360.47,363.094,364.798,368.758,373.134,377.55,379.218,383.177,387.553,391.929,394.553,398.929,403.305,405.04900000000004,406.657,411.033,413.281,414.991,420.279,424.655,429.031,430.734,432.438,436.438,438.122,443.826,448.201,452.577,454.281,456.489,460.905,462.556,468.26,472.636,476.596,480.971,485.347,487.971,491.931,496.307,498.555,500.2,504.576,508.952,513.328,517.704,519.952,521.629,526.005,528.629,533.005,535.629,537.837,542.213,546.589,550.965,555.192,559.568,563.944" y="187.26199999999994" svg_rhmargin="566.192" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Patients in Ginnir Referral Hospital. American Journal of Public Health Research. 2014; 2(6):239–43.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="200.30100000000004" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">35. </text>
  <text x="221.499,227.707,230.331,234.707,239.082,243.458,245.162,249.122,253.498,255.706,257.41,261.694,266.11,267.817,275.352,281.056,283.304,284.995,292.531,296.907,299.531,301.234,305.65,307.331,313.035,317.411,321.787,323.491,325.699,330.115,331.766,337.974,340.598,344.974,349.35,353.726,355.43,359.39,363.766,365.974,367.678,371.961,376.377,378.084,382.46,384.164,388.54,392.916,397.292,399.036,400.704,402.912,407.288,411.664,416.04,418.664,422.624,427.0,428.597,432.973,436.933,438.637,442.637,444.301,448.261,452.637,457.013,459.221,461.845,466.22,467.96400000000006,469.643,472.267,476.643,481.019,485.395,488.019,490.267,491.922,496.298,500.674,505.05,509.426,511.674,513.353,519.561,521.265,525.641,530.016,534.392,536.1360000000001,537.787,539.995,544.371,548.747,553.123,555.747,559.706,564.082,565.786,570.162" y="200.30100000000004" svg_rhmargin="572.826" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Organization WH. World Health Organization global tuberculosis control report 2009. Global tuberculo-</text>
  <text x="221.499,225.459,227.163,231.163,232.838,236.798,241.174,245.55,247.758,250.382,254.757,256.461,258.709,260.39,264.766,269.142,273.518,277.894" y="209.769" svg_rhmargin="280.142" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">sis control. 2011.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="222.75199999999995" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">36. </text>
  <text x="221.499,225.875,227.579,231.955,236.331,238.954,243.33,245.538,247.282,248.938,254.226,256.474,258.179,263.467,265.171,267.379,274.003,278.379,282.795,284.427,290.131,296.339,298.587,300.302,305.174,309.55,311.758,315.717,317.421,321.797,324.005,326.253,327.911,331.871,334.11899999999997,335.791,342.415,346.791,348.495,351.119,355.495,361.23900000000003,362.947,368.651,370.899,372.585" y="222.75199999999995" svg_rhmargin="378.833" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Liberati A, Altman DG, Tetzlaff J, Mulrow C, G</text>
  <text x="378.793" y="222.75199999999995" svg_rhmargin="383.681" style="fill:#000000;font-family:FTHCNZ+ArialMT;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ø</text>
  <text x="383.641,385.849,389.809,393.769,397.728,402.104,406.52,408.131,413.419,419.123,421.371,423.098,425.306,429.682,434.058,438.434,442.81,444.513,448.78,450.484,454.484,456.206,460.166,465.454,467.702,469.416,473.792,476.03999999999996,477.693,482.069,483.773,486.021,487.727,492.599,496.975,501.391,503.091,508.379,514.083,516.291,521.579,528.203,533.531,535.18,539.14,541.347,545.723,547.931,552.307,558.931,563.307,567.683" y="222.75199999999995" svg_rhmargin="569.931" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tzsche PC, Ioannidis JP, et al. The PRISMA statement</text>
  <text x="221.499,223.707,228.083,230.74699999999999,232.44,235.064,239.44,243.816,248.192,250.816,253.024,254.728,259.104,263.52,265.153,269.112,273.072,277.032,279.24,283.616,290.24,294.616,296.824,298.528,302.528,304.157,306.781,311.157,315.117,316.821,321.197,326.901,330.901,332.56,336.936,341.312,345.728,347.413,354.037,358.413,360.621,364.997,367.621,371.997,376.373,380.635,382.339,386.299,390.259,394.635,398.635,400.308,404.684,406.932,408.641,412.601,414.809,419.185,423.561,425.265,429.641,433.641,435.287,437.495,441.871,446.247,448.495,450.197,454.573,458.533,462.909,464.612,468.988,473.364,475.572,479.988,481.605,485.981,490.357,494.733,496.437,498.645,503.061,504.735,508.695,513.071,515.695,520.1110000000001,521.743,523.447,527.823,530.031,534.407,537.031,540.991,545.367,549.743,551.951,553.655,558.031,562.407,566.247" y="232.27599999999995" svg_rhmargin="568.495" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions:</text>
  <text x="221.499,225.875,229.835,234.211,235.915,240.29,244.666,248.938,251.146,252.85,257.226,261.642,263.338,267.714,272.09,276.506,278.192,282.568,284.272,288.647,293.023,297.399,300.023,304.399,306.607,308.311,312.687,316.97,319.218,320.937,326.225,330.601,334.977,340.30499999999995,341.971,348.595,352.971,357.347,359.051,363.011,364.715,369.09,373.466,375.714,377.347,381.723,386.099,390.475,394.851,397.099,398.776,403.152,405.776,410.152,412.776,414.984,419.36,423.736,428.112,432.488,436.761,441.137,445.513,449.889,452.137,453.769,458.145,460.353,462.561,466.936,470.896,473.104,475.312,477.52,481.896,486.272,487.976,490.184,494.56,497.082,501.458,503.666,508.042,512.417,514.625,519.001,523.377,527.753,532.129,534.337,536.041,540.417,544.647,547.271,551.647,556.023,557.727" y="241.80100000000004" svg_rhmargin="559.975" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">explanation and elaboration. PLoS medicine. 2009; 6(7):e1000100. https://doi.org/10.1371/journal.</text>
  <text x="221.499,225.875,232.499,236.875,241.25,243.458,247.834,252.21,256.478,260.854,265.23,269.606,274.022,275.697,280.985,287.609,289.817,295.521,297.769,299.451,303.827,308.203,312.579,316.955,321.331,325.586,329.962" y="251.26800000000003" svg_rhmargin="334.378" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">pmed.1000100 PMID: 19621070</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="264.251" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">37. </text>
  <text x="221.499,227.203,228.907,233.283,237.659,239.363,243.738,247.738,249.392,253.352,258.64,260.888,262.601,267.473,271.849,276.225,282.849,287.225,291.061,295.437,299.853,301.549,306.837,313.045,315.293,317.026,322.73,327.106,331.482,335.442,339.442,341.064,345.024,348.984,351.23199999999997,352.912,358.2,359.904,362.112,368.736,373.112,377.528,379.218,384.921,391.129,393.377,395.035,401.659,406.035,410.411,414.371,418.747,421.371,423.075,427.35,431.766,433.473,435.177,439.553,443.513,447.889,452.265,456.225,457.929,461.889,464.096,468.472,472.848,476.808,480.808,482.399,484.103,488.519,490.222,496.846,501.222,503.43,507.806,510.43,514.805,519.181,523.557,525.261,529.113,533.073,537.449,541.409,543.657,545.384,550.672,557.296,561.256" y="264.251" svg_rhmargin="563.504" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ:</text>
  <text x="221.499,226.787,229.411,231.115,233.323,235.027,238.987,243.403,245.083,251.707,256.083,260.459,262.163,266.123,270.499,272.24300000000005,273.883,277.843,282.219,286.595,289.219,293.595,297.971,299.675,301.923,303.59,307.966,312.342,316.718,321.094,323.342,324.963,329.339,333.715,338.091,340.715,345.091,349.467,353.843,358.219,360.736,362.944,367.32,371.696,376.072,378.32,380.011,384.387,386.595,388.803,393.179,397.139,399.347,401.555,403.763,408.139,412.515,414.219,416.427,420.803,423.325,427.701,429.909,434.285,438.661,440.869,445.245,449.621,453.882,458.258,460.466,464.842,471.466,473.17,475.378,479.754,484.13,488.408,490.616,494.992,499.368,503.744,508.12,510.328,514.704,519.08,523.4960000000001,525.145,530.432,537.056,539.264,544.968" y="273.775" svg_rhmargin="547.216" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">British Medical Journal. 2003; 327(7414):557. https://doi.org/10.1136/bmj.327.7414.557 PMID:</text>
  <text x="221.499,225.875,230.251,234.627,239.003,243.378,247.754,252.13" y="283.29999999999995" svg_rhmargin="256.546" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">12958120</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="296.282" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">38. </text>
  <text x="221.499,226.787,231.163,235.539,238.163,242.538,244.242,248.658,250.298,255.586,260.874,263.122,264.812,269.188,270.892,275.268,279.644,281.852,283.556,287.932,290.555,294.971,296.617,301.905,304.15299999999996,305.858,311.562,315.938,318.146,322.521,325.145,331.769,333.473,337.849,342.225,346.506,348.714,352.714,354.387,358.763,361.01099999999997,362.72,364.928,367.552,371.928,376.304,378.512,385.136,389.512,393.888,396.13599999999997,397.757,402.133,406.508,410.884,415.26,417.884,422.26,426.636,430.596,435.012,436.647,441.023,447.647,452.023,456.399,460.815,462.443,466.403,473.027,477.403,481.779,484.403,487.027,491.403,495.779,499.633,501.337,503.545,505.249,509.209,513.625,515.337,519.713,524.089,525.793,532.417,536.792,541.168,545.441,548.065,552.065,553.775,555.983,560.359,564.734,569.11,571.734" y="296.282" svg_rhmargin="574.398" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Shargie EB, Lindtjorn B. Determinants of treatment adherence among smear-positive pulmonary tuber-</text>
  <text x="221.499,225.459,229.835,231.539,235.915,239.875,241.578,245.578,247.238,251.614,255.99,258.197,259.901,264.277,268.653,270.861,274.861,276.491,278.195,282.611,284.314,289.602,293.978,298.354,300.562,304.938,309.314,311.938,316.354,317.99,323.277,325.485,329.861,331.565,335.941,340.317,342.021,346.397,348.645,350.304,355.592,359.968,364.344,369.67199999999997,371.338,377.962,382.338,386.713,388.961,390.613,394.989,399.365,403.741,408.117,410.365,412.043,416.419,419.043,423.419,426.043,428.251,432.626,437.002,441.378,443.626,445.265,449.641,451.849,454.057,458.433,462.393,464.6,466.808,469.016,473.392,477.768,479.472,481.68,486.056,488.578,492.954,495.162,499.538,503.914,506.122,510.498,514.874,519.135,523.511,525.719,527.423,531.799,536.175,538.799,543.175,547.551,549.255,551.463,555.839,562.463,566.701,571.077" y="305.806" svg_rhmargin="573.325" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">culosis patients in Southern Ethiopia. PLoS Med. 2007; 4(2):e37. https://doi.org/10.1371/journal.pmed.</text>
  <text x="221.499,225.875,230.251,234.627,239.003,243.378,247.754,252.17,253.814,259.101,265.725,267.933,273.637,275.885,277.511,281.887,286.263,290.639,295.015,299.391,303.767,308.142" y="315.274" svg_rhmargin="312.558" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">0040037 PMID: 17298164</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="328.257" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">39. </text>
  <text x="221.499,227.203,231.579,235.539,239.915,244.29,248.29,249.958,255.662,260.95,263.198,264.869,271.493,275.452,281.156,285.532,289.908,294.179,295.883,300.299,302.003,307.706,309.954,311.697,317.905,322.281,324.905,329.32099999999997,330.973,336.26,341.548,343.796,345.486,352.11,356.486,360.862,363.07,367.446,371.822,376.198,380.614,382.222,387.51,389.758,391.464,393.672,398.048,400.256,404.632,407.256,411.216,415.592,419.967,422.175,423.779,428.155,432.531,436.531,438.235,440.443,444.819,447.483,449.177,453.553,457.929,459.633,464.009,465.713,470.088,474.504,476.162,480.538,484.914,487.122,488.826,493.202,497.578,499.786,503.786,505.416,507.624,512.0400000000001,513.75,515.957,520.333,522.037,523.741,528.117,533.861,535.52,539.896,542.52,546.895,550.855,554.815,557.439,559.143,563.519" y="328.257" svg_rhmargin="566.183" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescrip-</text>
  <text x="221.499,223.707,225.411,229.787,234.163,238.163,239.867,242.075,246.451,249.11499999999998,250.809,257.433,261.809,266.185,267.889,271.848,276.224,278.305,280.009,284.385,288.761,292.721,294.969,296.673,302.377,306.753,310.713,315.089,317.713,322.089,326.465,330.881,332.503,338.207,342.583,344.791,349.167,353.543,357.919,361.879,366.295,367.936,373.224,377.184,381.144,383.392,385.057,390.761,395.137,399.097,401.34499999999997,403.028,407.404,411.78,416.156,420.532,422.78,424.459,428.835,431.458,435.834,440.21,442.834,445.042,449.418,451.501,455.877,460.253,464.629,466.836,471.212" y="337.781" svg_rhmargin="473.46" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tions for medications. Cochrane Database Syst Rev. 2002; 2(11):7.9–1.4.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="350.764" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">40. </text>
  <text x="221.499,227.203,231.579,235.955,237.659,242.034,245.994,250.41,252.056,257.76,262.632,264.88,266.569,271.857,275.817,280.193,281.897,285.857,290.273,291.911,297.199,302.903,305.151,306.878,312.582,316.958,321.333,323.037,324.781,326.437,330.397,336.604,338.852,340.553,346.257,351.961,353.665,358.041,362.457,364.138,370.346,375.634,377.882,379.558,384.846,386.55,388.254,392.63,394.838,399.214,401.878,403.539,409.747,415.451,417.699,419.413,426.037,430.413,434.789,439.165,443.541,447.957,449.574,451.781,457.069,459.317,461.025,465.401,467.649,469.359,473.735,475.439,477.687,479.337,484.625,489.001,493.377,497.753,500.377,504.753,509.129,513.089,517.5050000000001,519.135,521.343,525.759,527.469,533.173,535.797,540.173,544.589,546.292,552.915,557.291,561.667,563.371,567.331,571.707" y="350.764" svg_rhmargin="574.371" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Ubajaka CF, Azuike EC, Ugoji JO, Nwibo OE, Ejiofor OC, Modebe IA, et al. Adherence to Drug Medica-</text>
  <text x="221.499,223.707,225.411,229.787,234.163,238.163,239.867,244.243,250.867,255.243,259.619,263.995,267.817,270.065,271.785,276.657,281.033,285.409,289.785,292.409,296.369,300.745,302.449,306.825,310.676,312.38,316.38,318.103,323.391,327.767,329.975,331.679,336.055,340.431,342.639,346.639,348.32,350.024,354.44,356.144,360.56,362.267,367.139,371.514,374.138,376.346,378.05,382.426,385.05,389.05,390.669,396.373,400.749,405.125,406.829,409.037,413.453,415.104,417.312,421.688,425.648,427.856,429.56,431.768,436.144,438.352,440.056,444.432,448.848,450.481,452.185,456.601,458.361,463.648,468.024,472.4,474.608,479.024,480.641,485.929,490.305,494.265,496.513,498.216,503.92,505.624,510.0,514.376,517.0,518.704,523.08,525.3280000000001,526.959,529.167,533.543,535.751,540.127,542.751,547.127,551.503,553.711,555.415,559.791,564.167,568.542" y="360.288" svg_rhmargin="570.286" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tions amongst Tuberculosis Patients in a Tertiary Health Institution in South East Nigeria. International</text>
  <text x="221.499,225.459,229.835,234.211,236.835,241.21,245.586,247.33,248.995,253.371,255.619,257.329,263.033,264.737,266.441,270.817,272.521,276.48,280.856,282.6,284.258,290.882,295.258,299.634,301.338,305.298,307.002,311.378,315.754,318.002,319.634,324.009,328.385,332.761,337.137,339.385,341.064,345.44,348.064,352.44,356.815,359.439,361.647,366.023,370.399,374.775" y="369.756" svg_rhmargin="377.023" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Journal of Clinical Medicine. 2015; 6(06):399.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="382.795" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">41. </text>
  <text x="221.499,226.787,231.163,235.539,237.243,241.659,243.326,248.198,250.446,252.17,259.705,264.081,266.705,270.665,272.40900000000005,274.053,279.341,281.589,283.294,288.582,292.958,295.166,296.87,301.246,305.622,307.87,309.542,313.918,318.294,322.67,325.294,329.254,333.63,340.254,344.522,346.226,347.93,352.306,356.682,360.642,365.058,366.746,372.45,374.154,376.362,380.778,382.45,386.825,389.449,393.825,398.241,399.911,402.535,406.911,411.287,412.991,419.615,423.991,428.367,430.575,434.575,436.194,438.402,442.778,445.442,447.136,451.096,455.472,458.096,462.472,466.848,468.552,472.552,474.235,478.611,480.315,484.275,488.651,493.027,496.987,501.362,505.362,506.946,508.65,513.066,514.826,519.202,523.578,526.202,528.41,532.786,538.49,542.866,546.688,548.936,550.656,555.944,558.152,562.528,564.232,568.608" y="382.795" svg_rhmargin="571.272" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Abula T, Worki A. Patient non-compliance with drug regiments for chronic diseases in northwest Ethio-</text>
  <text x="221.499,225.875,227.579,231.955,234.203,235.899,241.187,243.394,247.77,249.474,253.85,258.226,259.93,264.306,268.722,270.368,274.328,278.704,283.08,285.704,290.079,294.455,296.199,297.807,302.183,304.431,306.141,311.845,316.221,320.597,322.301,324.509,328.925,330.633,336.337,340.712,344.672,349.048,350.752,355.128,359.375,365.999,370.375,374.751,376.959,379.207,380.918,385.294,389.67,394.046,398.422,400.67,402.292,406.668,411.044,413.668,418.044,420.667,422.875,427.251,431.627,436.003,440.276,444.652,449.028" y="392.263" svg_rhmargin="451.276" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">pia. Ethiopian Journal of Health Development. 2001; 15(3):185–92.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="405.302" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">42. </text>
  <text x="221.499,228.123,229.827,233.787,238.163,242.538,246.914,248.658,250.298,255.586,257.834,259.54,264.828,269.204,270.908,275.284,279.244,283.62,287.996,293.74,295.369,300.241,302.489,304.214,308.174,309.878,312.502,316.918,318.614,324.317,326.565,328.251,333.123,337.499,341.875,346.251,348.875,352.835,357.211,358.808,363.184,367.144,368.848,372.848,374.569,378.945,383.321,385.529,389.905,394.281,395.985,398.193,402.462,405.086,409.086,410.796,413.004,415.628,420.003,426.667,428.371,430.579,434.954,439.33,442.162,443.847,448.223,452.599,454.807,458.767,461.599,463.237,465.86,470.236,474.612,476.316,482.94,487.316,491.73199999999997,493.397,495.101,499.517,501.22,505.18,506.884,513.508,520.132,524.548,526.222,530.182,534.558,538.934,543.31,545.558,547.198,551.158,555.534,559.91,562.118,566.494" y="405.302" svg_rhmargin="569.158" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Michael K, Belachew T, Jira C. Tuberculosis defaulters from the" dots" regimen in Jimma zone, south-</text>
  <text x="221.499,227.203,231.579,235.539,237.78699999999998,239.471,244.759,246.966,251.342,253.046,257.422,261.798,263.502,267.878,270.126,271.785,277.073,279.281,283.657,285.361,289.737,294.113,295.817,300.193,304.609,306.255,312.878,317.254,321.63,323.334,327.294,331.67,333.41400000000004,335.054,336.758,341.134,345.51,348.134,352.51,356.886,358.59,360.83799999999997,362.494,366.87,371.246,375.622,379.998,382.246,383.866,388.242,392.618,395.242,399.618,402.242,404.45,408.826,413.202,417.578,421.851,426.227,430.603,432.851,434.55,439.838,446.462,448.67,454.373,456.621,458.304,462.68,467.056,471.432,475.808,480.184,484.56,488.936" y="414.77" svg_rhmargin="493.352" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">west Ethiopia. Ethiopian medical journal. 2004; 42(4):247–53. PMID: 16124124</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="427.752" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">43. </text>
  <text x="221.499,226.371,230.747,234.707,236.411,240.827,242.475,247.763,250.011,251.716,258.34,262.716,265.34,267.044,271.42,278.084,279.779,285.483,287.731,289.416,294.704,296.408,298.15200000000004,299.848,305.136,307.384,309.089,314.793,319.169,321.377,325.753,330.129,331.833,334.041,335.745,340.121,344.537,346.166,348.374,350.998,355.374,362.038,363.741,369.445,375.653,380.525,385.85299999999995,387.495,391.871,396.247,400.663,402.349,404.052,406.26,410.26,411.986,416.362,420.738,422.946,427.322,429.946,436.57,438.274,442.543,446.919,451.295,453.503,457.503,459.211,460.915,465.331,467.035,469.243,473.619,476.243,480.619,485.035,486.708,491.083,492.787,496.747,498.955,501.579,503.283,507.243,509.451,513.451,515.054,519.43,521.678,523.387,528.675,531.299,535.259,537.003,538.694,543.566,547.942,552.318,556.734,558.423,560.127" y="427.752" svg_rhmargin="564.543" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Tekle B, Mariam D, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in</text>
  <text x="221.499,226.787,228.995,233.371,235.075,239.451,243.827,245.531,249.906,252.154,253.814,258.686,263.061,267.477,269.121,271.329,275.705,277.913,282.288,284.912,289.288,293.664,295.872,297.576,301.952,306.328,310.704,312.44800000000004,314.078,318.038,322.414,326.789,329.413,333.789,338.165,339.90900000000005,341.574,345.95,348.198,349.908,354.78,359.155,363.531,367.907,370.531,374.491,378.867,380.465,384.841,388.801,390.505,394.505,396.169,400.545,404.921,409.337,411.023,415.399,419.775,424.151,428.567,430.241,435.945,437.649,441.609,445.985,450.361,454.321,458.697,460.945,462.613,466.989,471.365,475.74,480.116,482.364,483.986,488.362,490.986,495.362,497.986,500.194,504.57,508.946,513.322,517.698,521.97,524.2180000000001,525.938,531.226,537.85,540.058,545.762" y="437.277" svg_rhmargin="548.01" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Ethiopia. The International Journal of Tuberculosis and Lung Disease. 2002; 6(7):573–9. PMID:</text>
  <text x="221.499,225.875,230.251,234.627,239.003,243.378,247.754,252.13" y="446.802" svg_rhmargin="256.546" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">12102295</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="459.784" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">44. </text>
  <text x="221.499,228.123,232.499,236.875,239.499,243.915,245.594,250.882,256.17,258.418,260.106,264.482,268.858,274.562,276.266,280.682,282.33,287.618,292.906,295.154,296.843,302.131,308.755,310.459,312.667,317.08299999999997,318.783,324.487,328.447,330.695,332.333,337.621,341.997,346.373,350.749,352.49300000000005,354.216,360.84,366.128,368.376,370.034,374.906,377.53,381.906,384.114,388.489,392.865,394.569,401.233,402.859,408.147,410.395,412.1,417.388,421.763,423.467,430.091,431.795,436.171,440.171,441.863,445.823,448.07099999999997,449.744,455.032,459.408,461.616,463.32,467.696,472.072,474.32,475.992,480.368,484.744,489.12,493.496,496.12,500.496,504.872,508.704,513.12,514.826,517.034,521.45,523.161,525.369,529.745,534.12,538.496,541.12,545.08,549.456,551.16,555.536,559.387,561.091" y="459.784" svg_rhmargin="565.091" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis</text>
  <text x="221.499,223.707,226.331,230.707,235.083,237.291,243.915,248.29,252.666,254.874,257.122,258.746,263.162,264.869,268.829,272.789,276.749,278.956,283.332,289.956,294.332,296.54,298.244,302.244,303.873,306.497,310.873,314.833,316.537,320.913,326.65700000000004,328.308,332.684,334.932,336.641,341.017,345.393,349.769,351.473,353.177,355.385,359.761,361.87,363.574,367.534,371.95,373.662,376.286,380.662,384.622,388.997,393.373,395.997,399.957,404.333,406.581,408.244,413.532,417.908,422.284,427.61199999999997,429.278,435.902,440.278,444.654,446.358,450.318,452.022,456.397,460.773,463.021,464.653,469.029,473.405,477.781,482.157,484.405,486.027,490.403,493.027,497.403,500.026,502.234,506.61,510.986,515.362,519.738,521.9860000000001,523.614,527.99,530.198,532.406,536.782,540.742,542.95,545.158,547.366,551.742,556.118,557.822,560.03,564.406,566.927,571.303" y="469.252" svg_rhmargin="573.551" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">treatment: a systematic review of qualitative research. PLoS medicine. 2007; 4(7):e238. https://doi.org/</text>
  <text x="221.499,225.875,230.251,232.459,236.835,241.211,245.587,249.962,252.056,253.76,258.136,262.512,265.136,269.512,273.888,275.592,277.8,282.176,288.8,293.176,297.551,299.759,304.043,308.419,312.795,317.171,321.547,325.923,330.339,331.937,337.225,343.848,346.056,351.76,354.008,355.691,360.067,364.443,368.819,373.195,377.57,381.946,386.322" y="478.775" svg_rhmargin="390.738" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">10.1371/journal.pmed.0040238 PMID: 17676945</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="491.759" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">45. </text>
  <text x="221.499,226.371,228.995,230.699,235.075,239.451,243.827,248.243,249.902,254.774,260.478,262.726,264.415,269.703,274.079,278.455,281.079,285.455,289.831,292.455,296.871,298.487,302.447,307.735,309.983,311.697,316.985,319.609,323.985,330.609,334.985,337.193,338.796,343.172,347.588,349.284,353.66,358.036,362.412,366.788,369.412,373.788,378.164,382.124,386.54,388.175,390.383,394.799,396.509,398.717,401.341,405.717,410.093,412.301,418.925,423.301,427.677,429.925,431.545,433.753,438.129,440.793,442.487,444.695,449.071,453.447,457.823,460.447,464.407,468.783,470.38,474.756,478.716,480.42,484.38,486.628,488.352,490.559,494.935,499.351,500.994,502.698,509.322,513.698,518.074,520.698,522.905,527.281,531.657,535.52,539.936,541.642,546.018,548.2660000000001,549.976,554.352,556.056,558.68,563.056,567.016" y="491.759" svg_rhmargin="569.264" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Frieden TR, Sbarbaro JA. Promoting adherence to treatment for tuberculosis: the importance of direct</text>
  <text x="221.499,225.875,230.251,234.211,238.587,241.211,245.171,249.546,251.754,253.458,257.726,262.102,264.34999999999997,266.059,271.347,275.723,277.427,279.131,283.507,285.715,287.419,291.835,293.499,297.875,300.123,301.832,304.04,308.416,312.832,314.531,322.067,326.443,329.067,330.771,335.187,336.869,342.573,346.948,351.324,353.028,355.236,359.652,361.303,367.511,370.135,374.511,378.886,383.262,384.966,388.926,393.302,395.375,397.079,401.455,405.831,408.079,409.775,414.151,418.527,422.903,427.279,429.527,431.205,435.581,439.957,442.165,446.541,450.917,455.293,459.669,464.045,466.293,467.942,472.318,474.526,476.734,481.11,485.07,487.278,489.372,491.579,495.955,500.331,502.035,504.243,508.619,511.243,515.619,517.827,522.203,526.579,528.787,533.163,537.447,541.823,546.199,548.407,552.783,557.159" y="501.282" svg_rhmargin="559.407" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">observation. Bulletin of the World Health Organization. 2007; 85:407–9. https://doi.org/10.2471/06.</text>
  <text x="221.499,225.875,230.251,234.627,239.003,243.379,247.795,249.448,254.736,261.36,263.568,269.272,271.52,273.203,277.579,281.955,286.331,290.707,295.083,299.338,303.714" y="510.75" svg_rhmargin="308.13" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">038927 PMID: 17639230</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="523.79" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">46. </text>
  <text x="221.499,226.787,231.163,235.539,237.747,242.123,246.539,248.201,253.073,255.321,256.989,263.197,267.573,270.197,274.613,276.321,282.024,284.272,285.959,290.831,293.455,295.159,299.535,303.911,308.287,312.703,314.362,319.234,321.48199999999997,323.206,328.909,333.285,337.661,342.037,346.413,349.037,353.309,357.269,361.645,365.605,369.981,372.605,376.981,381.397,383.016,388.304,390.55199999999996,392.258,397.545,401.921,406.297,408.921,413.297,419.921,424.297,428.673,430.41700000000003,432.055,437.759,440.007,441.693,447.901,452.277,456.653,458.39700000000005,460.061,465.349,467.597,469.303,473.679,475.92699999999996,477.636,482.012,483.716,485.964,487.671,493.375,495.079,499.039,503.039,504.735,506.943,511.319,515.279,517.487,521.863,524.487,528.487,530.133,534.509,538.469,542.429,546.805,550.765,552.469,556.845,559.053,563.429" y="523.79" svg_rhmargin="567.845" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Santha T, Garg R, Frieden T, Chandrasekaran V, Subramani R, Gopi P, et al. Risk factors associated</text>
  <text x="221.499,227.203,228.907,231.115,235.531,237.203,241.579,245.955,248.163,252.538,256.914,258.618,260.826,263.074,264.755,266.963,271.339,273.043,274.747,279.123,281.747,286.163,287.829,292.205,296.581,300.997,302.683,307.059,311.435,315.81,318.018,322.43399999999997,324.113,328.489,335.113,339.489,343.865,348.281,349.908,352.116,356.492,360.867,365.243,367.867,371.827,376.203,377.801,382.177,386.137,387.841,391.841,393.561,397.937,402.313,404.521,406.225,410.601,414.977,417.185,421.185,422.815,425.023,427.647,432.023,436.399,438.607,442.982,447.398,449.063,450.767,455.183,456.887,461.303,463.009,468.713,474.921,479.793,485.121,486.764,491.139,493.763,498.139,502.515,505.139,509.515,516.139,522.763,527.1790000000001,528.773,530.477,534.893,536.653,541.525,543.229,545.853,550.229,554.189,558.565,560.269,561.882,566.258" y="533.2570000000001" svg_rhmargin="568.922" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur</text>
  <text x="221.499,227.203,228.907,232.867,235.075,237.699,239.403,243.363,245.571,247.819,249.505,254.793,259.169,263.545,265.753,270.169,271.785,273.993,278.369,282.745,284.449,288.825,291.073,292.762,297.138,301.514,305.89,310.266,312.514,314.191,319.063,323.439,327.855,329.555,331.763,336.139,338.347,342.723,345.347,349.723,353.99,356.198,357.902,362.278,366.654,371.03,372.774,374.456,378.416,382.792,387.168,389.792,394.168,398.544,400.288,401.952,406.328,408.57599999999996,410.285,415.157,419.533,423.909,428.285,430.909,434.869,439.245,440.842,445.218,449.178,450.882,454.882,456.547,460.923,465.299,469.715,471.401,475.776,480.152,484.528,488.944,490.619,496.323,498.027,501.987,506.362,510.738,514.698,519.074,521.322,522.99,527.366,531.742,536.118,540.494,542.7420000000001,544.364" y="542.7819999999999" svg_rhmargin="548.78" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">District, South India, 2000. The International Journal of Tuberculosis and Lung Disease. 2002; 6</text>
  <text x="221.499,224.123,228.499,231.123,233.331,237.707,242.083,246.459,250.834,255.21,257.458,259.086,264.374,270.998,273.206,278.91,281.158,282.84,287.216,291.592,295.968,300.344,304.72,308.975,313.351" y="552.307" svg_rhmargin="317.767" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">(9):780–8. PMID: 12234133</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="565.289" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">47. </text>
  <text x="221.499,226.787,231.163,235.539,239.915,244.331,245.991,251.278,253.52599999999998,255.231,260.519,267.143,271.519,275.895,277.639,279.325,285.533,287.781,289.473,294.761,299.137,303.097,307.473,309.177,313.593,315.212,320.5,322.748,324.453,329.741,334.117,338.493,342.869,347.285,348.944,355.568,357.816,359.546,364.834,368.794,373.17,375.378,377.586,382.002,383.64,388.928,391.176,392.881,398.169,400.793,405.169,409.128,413.504,415.208,419.584,423.96,427.803,432.219,433.927,438.303,442.678,447.094,448.78,453.156,455.78,460.156,464.572,466.241,468.865,473.241,477.201,478.905,482.865,485.073,489.449,493.825,497.785,502.201,503.828,508.204,510.828,515.204,517.412,519.116,520.82,525.2360000000001,526.902,531.278,533.5260000000001,535.236,541.86,545.82,549.779,554.155,558.531,562.907,566.757,568.965,573.341" y="565.289" svg_rhmargin="576.005" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacte-</text>
  <text x="221.499,224.123,225.827,230.203,236.867,238.563,240.771,245.147,249.523,253.899,256.523,260.483,264.859,266.456,270.832,274.792,276.496,280.496,282.216,283.92,287.88,292.256,293.96,298.336,300.544,304.92,309.336,310.96,313.168,315.792,320.168,326.832,328.535,332.911,337.287,338.991,345.615,349.991,354.367,358.639,361.263,365.263,366.972,369.18,373.556,377.932,382.308,384.932,388.892,393.268,394.865,399.241,403.201,404.905,408.905,410.625,415.001,419.377,421.585,423.289,427.665,432.041,434.249,438.249,439.879,444.255,446.463,448.671,453.047,457.423,461.799,463.503,467.879,472.295,473.952,476.16,481.864,486.28,487.955,492.331,496.707,501.083,502.787,504.491,508.491,510.122,514.498,518.874,522.833,527.209,528.913,531.121,535.497,537.201,541.201,542.889,544.593,549.009,550.713,556.001,560.377,564.337" y="574.7570000000001" svg_rhmargin="566.585" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">rium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East</text>
  <text x="221.499,227.707,232.083,233.787,235.491,239.867,246.53099999999998,248.201,252.161,256.537,260.913,265.289,267.537,269.177,273.553,277.929,280.553,282.761,287.137,292.841,297.217,301.177,303.425,305.064,310.352,312.56,316.936,318.64,323.016,327.392,329.096,333.472,335.71999999999997,337.379,342.667,349.291,355.03499999999997,356.711,361.087,365.463,369.839,371.543,373.247,377.247,378.878,383.254,387.63,392.006,393.71,395.917,400.293,402.541,404.22,408.596,412.972,417.348,421.724,423.972,425.649,430.025,434.401,436.609,440.985,445.361,449.737,451.985,453.598,457.974,460.182,462.39,466.766,470.726,472.934,475.142,477.35,481.726,486.102,487.806,490.014,494.39,496.912,501.288,503.496,507.872,512.248,514.456,518.832,523.208,527.584,531.834,534.042,538.002,542.378,546.754,551.13,555.506,559.882" y="584.281" svg_rhmargin="562.546" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Gojjam zone, northwest Ethiopia. BMC public health. 2015; 15:572. https://doi.org/10.1186/s12889-</text>
  <text x="221.499,225.875,230.251,234.627,237.251,241.627,246.003,250.378,254.754,257.272,261.688,263.395,268.683,275.307,277.515,283.219,285.467,287.149,291.525,295.901,300.277,304.653,309.029,313.405,317.65" y="593.8050000000001" svg_rhmargin="322.066" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">015-1933-9 PMID: 26092570</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="606.787" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">48. </text>
  <text x="221.499,227.203,231.579,233.283,237.659,242.035,243.779,245.423,251.127,256.831,259.079,260.787,266.995,269.619,271.323,273.027,277.403,279.107,283.067,287.483,289.133,294.837,301.045,303.293,305.007,310.711,315.087,319.047,320.751,325.167,326.834,330.794,336.082,338.33,339.987,345.691,350.067,352.691,357.067,361.443,364.067,369.771,374.147,380.77,385.146,389.422,393.422,395.149,401.357,403.605,405.297,411.0,415.416,417.088,422.376,427.664,429.912,431.602,436.474,440.85,444.81,447.018,451.394,454.018,458.018,459.665,464.041,468.0,471.96,476.336,480.296,482.0,486.376,488.584,492.96,497.376,499.01,504.714,506.418,508.626,513.042,514.714,516.922,521.297,525.7130000000001,527.413,531.789,536.164,540.54,543.164,547.124,551.5,558.124,562.392,564.096,568.472" y="606.787" svg_rhmargin="571.136" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Culqui DR, Grijalva CG, Cayla JA, Horna-Campos O, Ch KA. Factors associated with the non-comple-</text>
  <text x="221.499,223.707,225.411,229.787,234.203,235.899,240.275,242.523,244.233,248.193,252.569,256.945,260.905,265.281,269.657,271.865,273.569,277.945,282.216,286.592,288.336,290.04,294.416,298.792,301.0,302.704,305.328,307.536,311.912,316.176,320.552,323.176,327.136,331.512,333.216,337.592,341.552,343.256,347.256,348.944,351.152,353.776,358.152,362.528,364.736,371.36,375.736,380.112,382.36,383.98,385.684,390.1,391.804,397.092,401.468,404.092,408.468,410.716,412.383,417.671,420.295,424.255,428.631,430.335,434.295,438.671,442.671,444.301,448.677,453.093,454.789,460.077,462.701,467.077,471.453,475.413,479.789,484.165,488.541,492.917,499.406,503.782,505.486,509.862,514.238" y="616.255" svg_rhmargin="516.486" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tion of conventional anti-tuberculosis treatment in Peru. Archivos de Bronconeumologı</text>
  <text x="513.976" y="616.086" svg_rhmargin="516.64" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">´</text>
  <text x="516.414,520.83,522.537,525.161,530.449,534.824,539.2,540.904,542.608,546.568,550.984,552.641,557.929,562.305,564.009" y="616.255" svg_rhmargin="566.673" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">a (English Edi-</text>
  <text x="221.499,223.707,225.411,229.787,234.163,236.787,239.035,240.718,245.094,249.47,253.846,258.222,260.46999999999997,262.148,266.524,270.9,273.524,277.9,280.524,282.732,287.108,291.484,295.859,300.131,304.507,306.755,308.409,312.785,314.993,317.201,321.577,325.537,327.745,329.953,332.161,336.537,340.913,342.616,344.824,349.2,351.722,356.098,358.306,362.682,367.058,369.266,373.642,378.018,382.394,386.77,388.856,390.56,392.768,397.144,399.768,404.144,406.768,411.144,415.104,417.312,421.688,426.063,430.439,434.72,436.928,441.304,445.68,447.888,452.264,456.64,461.056,462.669,467.957,474.581,476.789,482.493,484.741,486.423,490.799,495.175,499.551,503.927,508.303,512.679,517.055" y="625.78" svg_rhmargin="521.471" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tion). 2012; 48(5):150–5. https://doi.org/10.1016/j.arbres.2011.12.008 PMID: 22377140</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="638.762" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">49. </text>
  <text x="221.499,227.707,232.083,233.787,240.411,244.786,249.162,253.538,257.386,261.802,263.508,265.716,267.964,269.688,274.976,279.352,283.312,287.688,292.064,296.023,297.727,302.003,306.419,308.125,313.413,315.661,317.366,323.574,327.95,329.654,334.03,338.406,342.366,346.742,348.446,352.406,356.782,360.623,365.039,366.746,372.034,374.282,375.986,381.274,385.65,388.274,392.65,396.61,398.314,402.69,407.106,408.755,414.043,416.291,417.996,423.283,425.491,428.115,432.491,434.195,435.899,439.899,441.58,446.868,452.156,454.404,456.093,461.381,465.757,470.133,474.509,478.469,482.885,484.496,490.704,495.992,498.24,499.917,504.293,506.541,508.25,512.626,514.33,516.5780000000001,518.285,523.573,527.949,530.573,533.196,534.9,539.276,541.9,545.9,547.595,549.803,554.219,555.872,559.832,564.208,568.168" y="638.762" svg_rhmargin="570.832" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Gelmanova I, Keshavjee S, Golubchikova V, Berezina V, Strelis AK, Yanova GV, et al. Barriers to suc-</text>
  <text x="221.499,225.459,229.835,233.795,237.755,239.963,244.338,246.082,247.747,249.955,254.331,258.707,263.083,265.707,269.667,274.043,275.641,280.016,283.976,285.68,289.68,291.401,293.609,296.233,300.609,304.985,307.193,313.817,318.193,322.569,324.817,326.437,328.141,332.557,334.261,339.133,343.508,350.132,354.092,358.052,360.3,361.927,367.631,372.007,375.966,379.926,381.63,386.006,390.42199999999997,392.087,396.959,401.335,405.711,410.087,412.711,417.087,419.186,420.89,425.266,429.642,431.89,433.587,437.962,442.338,446.714,449.338,453.714,458.09,462.466,466.842,469.359,473.735,478.111,482.071,486.447,488.695,490.392,494.768,499.144,501.352,505.728,510.104,511.808,514.056,515.677,520.053,524.429,528.845,530.531,532.739,537.115,541.5310000000001,543.23,547.606,551.566,555.942,560.318,562.022,565.982,567.686" y="648.287" svg_rhmargin="570.35" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">cessful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisi-</text>
  <text x="221.499,223.707,225.411,229.787,234.203,235.899,240.275,242.523,244.233,250.857,255.233,256.937,259.145,260.849,265.225,267.849,272.125,276.541,278.248,280.872,285.248,289.208,290.912,294.872,297.08,301.456,305.832,309.792,314.168,316.416,318.046,323.334,327.71,329.414,331.118,335.494,337.702,339.406,343.822,345.486,349.862,352.11,353.82,356.027,360.403,364.819,366.519,374.054,378.43,381.054,382.758,387.174,388.856,394.56,398.936,403.312,405.016,407.224,411.64,413.29,419.498,422.122,426.498,430.874,435.25,436.954,440.914,445.29,447.362,449.066,453.442,457.818,460.066,461.762,466.138,470.514,474.89,479.266,481.514,483.192,487.568,491.944,494.568,498.944,501.568,503.776,508.152,512.528,516.904,521.177,525.553,529.929,532.177,533.876,538.252,540.46,542.668,547.044,551.003,553.211,555.419,557.627,562.003,566.247,567.951" y="657.755" svg_rhmargin="570.199" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tion of multidrug resistance. Bulletin of the World Health Organization. 2007; 85(9):703–11. https://doi.</text>
  <text x="221.499,225.875,228.499,232.875,235.083,239.459,243.835,246.042,250.418,254.794,259.17,263.546,265.605,270.893,275.269,280.141,282.349,286.725,291.101,293.309,297.685,302.061,306.437,310.813,315.189,319.605,321.222,326.509,333.133,335.341,341.045,343.293,344.919,349.295,353.671,358.047,362.423,366.799,371.175,375.55" y="667.279" svg_rhmargin="379.966" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">org/10.2471/BLT.06.038331 PMID: 18026627</text>
  <path d=" M 576.0 737.0999755859375 L 36.0 737.0999755859375 L 36.0 737.5999755859375 L 576.0 737.5999755859375" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d="M453.769 242.879 L559.955 242.879 M221.498 252.346 L273.997 252.346 M299.451 252.346 L334.375 252.346 M380.013 274.854 L523.388 274.854 M221.498 284.377 L256.421 284.377 M445.265 306.885 L573.335 306.885 M221.498 316.352 L252.057 316.352 M277.511 316.352 L312.49 316.352 M458.305 415.848 L493.227 415.848 M221.498 447.88 L256.421 447.88 M523.616 470.33 L573.505 470.33 M221.498 479.855 L330.235 479.855 M355.691 479.855 L390.614 479.855 M467.942 502.361 L559.331 502.361 M221.498 511.829 L247.69 511.829 M273.203 511.829 L308.126 511.829 M282.841 553.386 L317.764 553.386 M453.6 585.36 L562.507 585.36 M221.498 594.884 L261.694 594.884 M287.149 594.884 L322.071 594.884 M308.408 626.86 L460.97 626.86 M486.424 626.86 L521.348 626.86 M533.877 658.835 L570.216 658.835 M221.498 668.358 L319.464 668.358 M344.92 668.358 L379.842 668.358 M576.0 62.9 L36.0 62.9 L36.0 62.4 L576.0 62.4 " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="36.0" y="35.042" height="23.698" width="107.15" title="15"/>
  <text x="36.0" y="35.042" class="image" id="image.15.1" width="107" height="23">image.15.1.36_143.35_59</text>
  <text x="279.836,285.124,287.748,292.124,296.084,300.46,302.164,306.54,310.916,314.758,319.174,320.881,325.257,329.633,334.049,335.734,340.11,344.486,346.694,351.07,353.694,360.318,362.022,366.292,370.668,375.044,377.252,381.252,382.96,387.335,389.58299999999997,391.293,395.669,400.045,402.253,403.957,406.581,408.789,413.165,417.541,421.794,424.418,428.378,432.754,434.458,438.834,442.794,444.498,448.498,450.197,452.405,455.029,459.405,463.781,465.989,472.613,476.989,481.365,483.613,485.233,489.609,493.985,498.361,500.985,505.361,509.737,514.113,518.489,521.006,525.382,529.758,533.718,538.134,539.771,541.475,545.8910000000001,547.595,552.883,555.091,559.467,561.171,565.547,569.923,571.627" y="54.20500000000004" svg_rhmargin="576.043" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia</text>
  <path d=" M 36.0 48.00019836425781 L 576.0 48.00019836425781 L 576.0 47.50019836425781 L 36.0 47.50019836425781" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d=" M 81.58110046386719 34.92279815673828 L 237.88299560546875 34.92279815673828 Z " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <text x="36.0,41.288,45.664,51.872,57.2,58.847,65.055,70.759,76.087,77.782,79.862,81.58,85.956,88.164,90.372,94.748,98.708,100.916,103.124,105.332,109.708,114.084,115.788,117.996,122.372,124.893,129.269,131.477,135.853,140.229,142.437,146.813,151.189,155.451,159.827,162.035,163.739,168.115,172.491,175.115,179.491,183.867,185.571,187.779,192.155,196.44,200.816,205.191,207.399,211.775,216.151,220.527,224.903,229.151,233.527,237.94299999999998,245.876,249.836,254.212,258.588,262.964,267.34,269.964,273.964,275.639,280.015,284.391,286.639,288.338,292.714,297.09,301.466,305.882,552.81,557.185,561.601,563.241,565.489,567.209,571.585" y="764.0" svg_rhmargin="576.001" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">PLOS ONE | https://doi.org/10.1371/journal.pone.0210422 January 10, 2019 15 / 15</text>
 </g>
</svg>
